Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction.
Bone marrow-mesenchymal stem cell (BM-MSC) therapy improves the recovery of cardiac function after myocardial infarction (MI); however, the underlying molecular mechanisms are not completely understood. Recent studies have shown that microRNAs (miRNAs) modulate the pathophysiology of cardiovascular...
Main Authors: | , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Acceso en liña: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179972&type=printable |